Dr. Bensch is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
4628 Georgetown Pl
Stockton, CA 95207Phone+1 209-478-6177Fax+1 209-478-6219
Education & Training
- University of North Carolina HospitalsResidency, Pediatrics, 1969 - 1971
- University of North Carolina HospitalsInternship, Pediatrics, 1968 - 1969
- University of North Carolina at Chapel Hill School of MedicineClass of 1968
Certifications & Licensure
- CA State Medical License 1973 - 2026
- NC State Medical License 1968 - 2018
- MT State Medical License 2002 - 2015
- CO State Medical License 1972 - 2005
- American Board of Allergy and Immunology Allergy & Immunology
- American Board of Pediatrics Pediatrics
Awards, Honors, & Recognition
- Fellow (FAAAAI) American Academy of Allergy Asthma and Immunology
Clinical Trials
- A Phase 1b Study of STMC-103H in Multi-Sensitized Allergic Subjects Who Are Otherwise Healthy Start of enrollment: 2018 Oct 10
- Phase 2 Study to Evaluate RPT193 in Adults With Moderate to Severe T2-high Asthma Start of enrollment: 2023 Jul 05
Roles: Contact
Publications & Presentations
PubMed
- 1 citationsLong-term safety and efficacy studies of epinephrine HFA metered-dose inhaler (Primatene® Mist): a two-stage randomized controlled trial.Edward Kerwin, Donald P. Tashkin, Phillip E. Korenblat, Leon S. Greos, David S. Pearlman
The Journal of Asthma. 2021-05-04 - 9 citationsForced Expiratory Flow (FEF25-75%) as a Clinical Endpoint in Children and Adolescents with Symptomatic Asthma Receiving Tiotropium: A Post Hoc Analysis.Stanley J. Szefler, Stanley Goldstein, Christian Vogelberg, George W Bensch, John Given
Pulmonary Therapy. 2020-05-12 - 1 citationsA Dose-Ranging Study of Epinephrine Hydrofluroalkane Metered-Dose Inhaler (Primatene® MIST) in Subjects with Intermittent or Mild-to-Moderate Persistent Asthma.Edward Kerwin, Donald P. Tashkin, Thomas R Murphy, George W. Bensch, Tony Marrs
Journal of Aerosol Medicine and Pulmonary Drug Delivery. 2020-03-06
Professional Memberships
- Fellow
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: